Evaluation of Cardiac Function With Cardio-respiratory Synchronized MRI

Sponsor
NYU Langone Health (Other)
Overall Status
Suspended
CT.gov ID
NCT02728284
Collaborator
(none)
100
1
2
64.1
1.6

Study Details

Study Description

Brief Summary

The purpose of this investigation is to evaluate newer methods of performing cardiovascular MRI (CMR) that will provide new kinds of information related to the interplay between the cardiac and the respiratory cycles, such as the interaction between the left ventricle and the right ventricle during respiration . The primary statistical objective is to provide preliminary indications of the relative utility of the investigational imaging software in terms of image quality and suitability for routine clinical use. Image quality will be expressed in terms of signal-to-noise ratios (SNR), contrast-to-noise ratios (CNR) and subjective Likert-type qualitative assessments independently provided by each of multiple blinded readers for each image. Suitability for routine use will be assessed in terms of imaging time and a binary indicator of whether, in the opinion of the investigator, adverse procedural complications (not expected) were encountered during a given imaging session.

Condition or Disease Intervention/Treatment Phase
  • Procedure: cardiovascular MRI (CMR)
  • Procedure: Conventional Cardiologic Evaluation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Evaluation of Cardiac Function With Cardio-respiratory Synchronized MRI
Actual Study Start Date :
Mar 29, 2018
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Normal Cardiovascular System

70 with a history of heart or lung disease

Procedure: cardiovascular MRI (CMR)
CMR is used to demonstrate cardiac abnormalities and assess cardiac function in many patients

Active Comparator: Abnormal Cardiovascular System

30 without any history of heart or lung disease

Procedure: Conventional Cardiologic Evaluation
ECG (gating), and respiratory motion effects

Outcome Measures

Primary Outcome Measures

  1. Image Quality measured by resolution [10 Minutes]

  2. Image Quality measured by signal to noise [10 Minutes]

  3. Suitability for routine use measured by imaging time and ease of use [10 Minutes]

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subjects will be selected as they are scheduled for clinical MR examinations.

  • Subjects will be selected on the basis of their willingness and ability to participate, on their comprehension of the informed consent document, on their likelihood of completing the study, and on the clinical appropriateness of the investigational technique for a given patient.

Exclusion Criteria:
  • electrical implants such as cardiac pacemakers or perfusion pumps

  • ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants

  • ferromagnetic objects such as jewelry or metal clips in clothing

  • pre-existing medical conditions including a likelihood of developing seizures or claustrophobic reactions, and any greater than normal potential for cardiac arrest.

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York University School of Medicine New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Leon Axel, New York University Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT02728284
Other Study ID Numbers:
  • 14-00601
First Posted:
Apr 5, 2016
Last Update Posted:
Jun 30, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by NYU Langone Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 30, 2022